Shanghai, China – September 22, 2025 – Lubrizol, a global leader in specialty chemicals, announced two key initiatives to strengthen its long-term commitment to China’s Medical industry. Lubrizol is actively expanding the local production capacity for medical-grade thermoplastic polyurethane (TPU) and has established the Lubrizol Center of Excellence for High-Performance Films. By making these strategic investments, Lubrizol deepens its focus on innovation-driven growth, localization, and collaborative development, while further demonstrating its dedication to supporting global markets and meeting the evolving needs of customers. These commitments directly address the rising demand for high-quality medical materials in China and will accelerate the development and commercialization of advanced medical film technologies.
“The expansion of our local capacity and the establishment of our Center of Excellence mark important milestones in Lubrizol’s ongoing efforts to deepen our presence in the local market and strengthen regional industry collaboration,” said Henry Liu, Vice President of Lubrizol Asia Pacific. “We are committed not only to providing customers and partners with faster responsiveness, more reliable supply chain assurance, and higher-value solutions, but also to integrating our global material science expertise with local needs—empowering customers to accelerate innovation and working together to build a more efficient and sustainable healthcare ecosystem.”
John Valukas, Senior Vice President and President of Lubrizol Engineered Polymers, added: “Innovation has always been central to Lubrizol’s mission. With decades of technical expertise and a strong track record in medical-grade TPU applications worldwide, we are proud to be at the forefront of industry advancement. Expanding our local production capacity and establishing the new Center of Excellence in China combine our global strengths with local capabilities. This allows us to respond quickly to the diverse needs of China’s medical sector, deliver greater value to our customers and partners, and ultimately improve patient outcomes.”
Increasing Local Investment to Enhance Supply Chain Resilience and Responsiveness
Lubrizol is expanding its medical-grade TPU manufacturing portfolio at its Shanghai Songjiang facility to address the growing demand for premium-quality medical materials in China and beyond. The expansion not only adds new momentum to Lubrizol’s existing local medical portfolio but also significantly improves responsiveness and supply chain reliability for customers across Asia Pacific. Leveraging the advantages of Lubrizol’s global manufacturing network, the upgraded local capacity provides dual benefits of localized service and global collaboration. This positions Lubrizol to not only support domestic growth but also to help Chinese medical device brands expand internationally with stronger supply assurance.
Establishing a Center of Excellence to Drive Local Innovation and Accelerate Commercialization
The newly established Lubrizol Center of Excellence for High-Performance Films integrates Lubrizol’s global material science capabilities with localized application development, creating a dynamic innovation platform. With comprehensive capabilities in TPU formulation, processing, and testing, the Center will support multiple industries, with a strong focus on medical applications. Beyond advancing innovations in dental films, the Center is expanding into next-generation medical film applications, helping customers accelerate R&D, enhance local innovation efficiency, and push the boundaries of medical material applications.
Source: Lubrizol
